WCG Unveils Strategic Alliance Program for CROs


WCG has launched a program to augment the existing capabilities of CROs and further support the work they do in driving innovation in clinical trials. By providing CROs with access to its clinical trial operations data, the WCG CRO Strategic Alliance Program enables CROs to better serve patients and research sponsors, and accelerate the pace at which new therapies are brought to market.

Read more about this new alliance program here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.